RPCI Physician, Colleagues Publish Findings from Phase III Study on Lenalidomide Maintenance for Myeloma Patients
Roswell Park Comprehensive Cancer CenterIn article in New England Journal of Medicine, Dr. Philip L. McCarthy and co-authors report significant time-to-progression benefit as well as survival benefit for patients who took maintenance doses of lenalidomide following stem-cell transplant.